Vontobel Holding Ltd. Has $874,000 Stock Holdings in Humana Inc. $HUM

Vontobel Holding Ltd. cut its stake in shares of Humana Inc. (NYSE:HUM) by 10.0% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,574 shares of the insurance provider’s stock after selling 397 shares during the period. Vontobel Holding Ltd.’s holdings in Humana were worth $874,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently modified their holdings of the company. Cary Street Partners Investment Advisory LLC raised its position in shares of Humana by 63.9% during the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 46 shares during the period. Garde Capital Inc. purchased a new position in shares of Humana during the first quarter valued at $36,000. Zions Bancorporation National Association UT purchased a new position in shares of Humana during the first quarter valued at $37,000. Ransom Advisory Ltd purchased a new position in shares of Humana during the first quarter valued at $66,000. Finally, Rakuten Securities Inc. grew its holdings in shares of Humana by 50.0% during the first quarter. Rakuten Securities Inc. now owns 300 shares of the insurance provider’s stock valued at $79,000 after buying an additional 100 shares in the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently weighed in on HUM. Piper Sandler lowered their price target on Humana from $288.00 to $272.00 and set a “neutral” rating on the stock in a report on Thursday, July 31st. Wolfe Research lifted their price target on Humana from $283.00 to $313.00 and gave the company an “outperform” rating in a report on Monday, October 6th. Bank of America lifted their price target on Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday. Evercore ISI began coverage on Humana in a report on Monday, September 22nd. They set an “in-line” rating and a $295.00 price target on the stock. Finally, Robert W. Baird lowered their price target on Humana from $300.00 to $297.00 and set a “neutral” rating on the stock in a report on Friday, July 25th. Eight analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $298.83.

Humana Stock Performance

HUM opened at $280.24 on Monday. The company has a market cap of $33.71 billion, a PE ratio of 21.51, a price-to-earnings-growth ratio of 1.64 and a beta of 0.42. The stock has a 50-day moving average of $279.45 and a 200-day moving average of $258.04. Humana Inc. has a 52-week low of $206.87 and a 52-week high of $315.35. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.95 and a current ratio of 1.95.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to the consensus estimate of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The business’s revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the company posted $6.96 EPS. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities research analysts forecast that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be paid a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 annualized dividend and a yield of 1.3%. Humana’s dividend payout ratio is presently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.